Senior insider sale
Chief Medical Officer at NUVATION BIO INC. — senior position signals high conviction
$363.1K
60K shares
What this filing means
LIU DONGFANG plans to sell 60K shares of NUVATION BIO INC. valued at approximately $363.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/25/2025ACC: 0001950047-25-009345
Officer· Chief Medical Officer
Since Jul 2022
60K
Shares to sell
$363.1K
Approx. market value
10K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
11/25/2025
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/25/2025 | Exercise of options under a registered plan Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
20K
Market value
$140.1K
11/20/2025
—Completed
Units to sell
15K
Market value
$76.6K
11/19/2025
—Completed
Units to sell
15K
Market value
$71.5K
11/17/2025
Planned — Approximate Date
NYSEPlanned
Units to sell
10K
Market value
$75.0K
11/25/2025
Total
Units
60K
Value
$363.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/20/2025 | 20K | $140.1K | — | Completed |
11/19/2025 | 15K | $76.6K | — | Completed |
11/17/2025 | 15K | $71.5K | — | Completed |
| Planned — Approximate Date | ||||
11/25/2025 | 10K | $75.0K | NYSE | Planned |
| Total | 60K | $363.1K | ||